Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026

Rhea-AI Summary

Champions Oncology (NYSE: CSBR) will report third-quarter results for the period ended January 31, 2026, on Thursday, March 12, 2026, after market close. The company will host a conference call the same day at 4:30 P.M. EDT (1:30 P.M. PDT).

Dial-in details: Domestic 888-506-0062, International 973-528-0011, access code 957548. A replay is available for 72 hours by dialing 877-481-4010 (Domestic) or 919-882-2331 (International), passcode 53731, or via the investors section of the company website.

News Market Reaction – CSBR

+2.44%

1 alert

+2.44% News Effect

On the day this news was published, CSBR gained 2.44%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Quarter end date: January 31, 2026 Earnings release date: March 12, 2026 Conference call time: 4:30 P.M. EDT +2 more

5 metrics

Quarter end date January 31, 2026 Third quarter fiscal period to be reported

Earnings release date March 12, 2026 Q3 FY2026 results to be reported after market close

Conference call time 4:30 P.M. EDT Start time for Q3 FY2026 earnings call

Domestic dial-in 888-506-0062 U.S. access number for earnings conference call

International dial-in 973-528-0011 Non-U.S. access number for earnings conference call

Market Reality Check

Price: $5.86 Vol: Volume 1,461 vs 20-day av...

low vol

$5.86 Last Close

Volume Volume 1,461 vs 20-day average 6,848, indicating muted trading interest ahead of earnings. low

Technical Shares at $6.00, trading below 200-day MA of $6.78 and about 45.75% under the 52-week high.

Peers on Argus

CSBR is flat while peers show mixed moves: declines in OVID, gains in QNCX, MGNX...

CSBR is flat while peers show mixed moves: declines in OVID, gains in QNCX, MGNX, and SRZN, suggesting stock-specific positioning rather than a clear sector trend.

Previous Earnings date Reports

1 past event · Latest: Dec 08 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	Move	Catalyst
Dec 08	Earnings date notice	Neutral	+0.2%	Announced date and call details for Q2 FY2026 results release.

Pattern Detected

Earnings date announcements have historically produced very small price moves, suggesting limited standalone impact.

Recent Company History

Over the past six months, Champions Oncology reported Q1 FY2026 revenue of $14.0 million with margin pressure and an operating loss, followed by record Q2 oncology revenue of about $15.0 million and improved profitability. Prior earnings date releases, such as the Q2 FY2026 scheduling on Dec 8, 2025, saw only a 0.16% move, indicating that investors generally wait for the full results rather than reacting to timing announcements alone.

Historical Comparison

+0.2% avg move · Past earnings date notices led to minimal moves around 0.16%, suggesting timing updates alone have n...

earnings date

+0.2%

Average Historical Move earnings date

Past earnings date notices led to minimal moves around 0.16%, suggesting timing updates alone have not been major trading catalysts for CSBR.

The company maintains a consistent pattern of pre-announcing quarterly earnings dates with accompanying conference call logistics.

Market Pulse Summary

This announcement schedules Champions Oncology’s third quarter FY2026 results for March 12, 2026 and...

Analysis

This announcement schedules Champions Oncology’s third quarter FY2026 results for March 12, 2026 and provides conference call logistics, without revealing new financial metrics. Historically, similar earnings date notices have produced minimal price impact, with an average move of about 0.16%. Investors may instead focus on prior trends in revenue growth, margins, and cash from recent quarters and will likely look to the forthcoming Q3 report for any change in trajectory.

AI-generated analysis. Not financial advice.

HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the third quarter ended January 31, 2026, on Thursday, March 12, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 957548. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53731, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.

Media Inquiries:

Gavin Cooper
Vice President, Global Marketing
gcooper@championsoncology.com

Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/

SOURCE: Champions Oncology, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Champions Oncology (CSBR) report Q3 2026 results and what is the timing?

Champions Oncology will report Q3 results for the period ended January 31, 2026, on March 12, 2026, after market close. According to the company, a conference call to discuss results is scheduled the same day at 4:30 P.M. EDT (1:30 P.M. PDT).

How can investors join the Champions Oncology (CSBR) March 12, 2026 conference call?

Investors can join by dialing Domestic 888-506-0062 or International 973-528-0011 and entering access code 957548. According to the company, those numbers and the access code will grant live participation on March 12 at 4:30 P.M. EDT.

Will a replay of the Champions Oncology (CSBR) Q3 2026 call be available and for how long?

Yes. A replay will be available for 72 hours after the call via domestic 877-481-4010 or international 919-882-2331 with passcode 53731. According to the company, the replay will also be posted in the investors section of the company website.

What time is the Champions Oncology (CSBR) conference call for Q3 results in Pacific Time?

The conference call is scheduled for 1:30 P.M. PDT on March 12, 2026. According to the company, this corresponds to 4:30 P.M. EDT and follows the release of results after market close.

Where can investors find the Champions Oncology (CSBR) Q3 2026 results if they miss the live call?

Investors can access the replay by phone for 72 hours or visit the investors section of the company website. According to the company, the website will host the replay within 72 hours of the March 12 call.